Alterity Therapeutics Limited | PRAN - 税前利润



金融业
股票价格
AUD
资产
AUD 37.98M
现金及等价物
AUD 15.77M
流动资产
AUD 37.91M
流动负债
AUD 1.73M
债务
AUD 210.39K
股息收益率
AUD 0
EBIT
AUD -8.07M
EBITDA
AUD -7.72M
员工
AUD 12
EPS每股收益
AUD 0
股本和储备
AUD 36.21M
贷款资金
AUD 43.68K
市值
AUD 36.8M
净收入
AUD -6.3M
营业费用
AUD 8.67M
营业利润
AUD -8.07M
普通股股本
AUD 10.88B
税前利润
AUD -4.74M
销售收入
AUD 596.04K
销售和管理费用
AUD 1.45M
贸易债权人
AUD 1.07M
应收帐款人
AUD 4.57M


税前利润 更改 日
Alterity Therapeutics Limited AUD -4.74M 3.53M 2024-12
Arca Biopharma USD -29.58M 694K 2025-12
aTyr Pharma USD -25.75M 6.22M 2025-09
Bio Path USD -976K 3.62M 2025-09
Brainstorm Cell Therapeutics USD -2.11M 797K 2025-09
Capricor Therapeutics USD -30.17M 5.6M 2025-12
Cara Therapeutics USD -4.91M 3.17M 2025-03
CSL USD 2.61B 1.21B 2025-12
Esperion Therapeutics USD 63.67M 95M 2025-12
Immunic USD -19.3M 6.28M 2025-12
Insmed USD -162.1M 164.84M 2026-03
Minerva Neurosciences USD 22.51M 30.74M 2024-09
Sangamo BioSciences USD -36.05M 12.94M 2024-06
TherapeuticsMD USD -1.05M 241K 2024-06